Great long term investment
Tandem has turned around. The company recently launched a new insulin pump algorithm and offers the best touch screen pump in the U.S. With international expansion just starting and a new FDA approval in sight next year, its market cap will easily double/triple. Watch out for $70 price level.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.